Search
Syndax Pharmaceuticals Inc
SNDXAdd to Watchlist
9.660USD
+0.290+3.10%
Market hours 11/06, 13:15（ET）
862.64MMarket Cap
LossP/E TTM
Syndax Pharmaceuticals Inc (SNDX) Stock Price Target & Forecast
Analyst Rating
Based on 12 analysts giving stock ratings to Syndax Pharmaceuticals Inc in the past month.
Buy
5 Strong Buy
7 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
38.727USD+183.72%
SNDX Analyst Recommendation Trends
In the current month, SNDX has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SNDX average Analyst price target in the last month is 38.727.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
5
5
6
6
6
6
6
6
7
7
7
8
8
8
8
8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
13
14
14
14
14
14
SNDX Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
IQVIA Holdings Inc
IQV
8
13
1
0
0
22
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, SNDX EPS is projected to reach -0.461 in FY2026Q4, following reported EPS of -0.551 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.58
-0.44
-0.49
-0.46
-0.08
Actual
-0.48
-0.55
-0.55
--
--
Surprise
+16.93%
-25.42%
-11.86%
--
--
FAQs
What is Syndax Pharmaceuticals Inc's expected revenue for the next quarter?
Syndax Pharmaceuticals Inc's expected revenue is 95.50M.
What is Syndax Pharmaceuticals Inc's price target?
Analysts forecast that Syndax Pharmaceuticals Inc's price target is USD 36.91, with the highest forecast at USD 57.00 and the lowest forecast at USD 17.00.
How have Syndax Pharmaceuticals IncSNDX's recent earnings per share performed?
The market expectation was USD -0.55, while Syndax Pharmaceuticals IncSNDX's earnings per share (EPS) for the previous quarter was USD -0.55. EPS for the next quarter is expected at USD -0.46.
What is the analyst rating for Syndax Pharmaceuticals Inc?
Based on the ratings of Syndax Pharmaceuticals Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.